Xiongfei Xu

机构：Macau University of Science and Technology, Second Military Medical University, University of Macau, Changhai Hospital, Eastern Hepatobiliary Surgery Hospital, Pancreatic Cancer UK · ORCID：0000-0001-9532-4582

发表论文 46 篇 · 总被引 2325 次 · h-index 20

代表论文

• The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I–peptide complex formation (2016 · Nature Immunology · 被引 112)
• Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity (2022 · Nature Communications · 被引 98)
• Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients (2020 · British Journal of Cancer · 被引 98)
• CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma (2017 · OncoImmunology · 被引 78)
• Melatonin suppresses TLR9-triggered proinflammatory cytokine production in macrophages by inhibiting ERK1/2 and AKT activation (2018 · Scientific Reports · 被引 46)
• Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase (2020 · Diabetes · 被引 45)